| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/11/2002 | US20020042395 Method of treating high plasma cholesterol levels |
| 04/11/2002 | US20020042392 Anticancer agents |
| 04/11/2002 | US20020042389 IGF-1 receptor interacting proteins |
| 04/11/2002 | US20020042385 Cloning of a novel 7TM receptor AXOR-2 |
| 04/11/2002 | US20020042375 Method of treating cancer |
| 04/11/2002 | US20020042373 Administering thrombin receptor antagonist; bone disorders |
| 04/11/2002 | US20020042372 Genetic engineering; central nervous system disorders |
| 04/11/2002 | US20020042370 Method of treating graft rejection using inhibitors of CCR2 function |
| 04/11/2002 | US20020042368 Integrin antagonists |
| 04/11/2002 | US20020042361 Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| 04/11/2002 | US20020042359 Regulators of PPARdelta (beta) and their use in the treatment of obesity and insulin resistance |
| 04/11/2002 | US20020042114 Novel human protein kinases |
| 04/11/2002 | US20020042101 Nucleotide sequences which code enzymatic polypeptide for use in the treatment of cancer, restenosis and diabetic neuropathy |
| 04/11/2002 | US20020042091 Methods and compositions for screening modulators of lipid kinases |
| 04/11/2002 | US20020042086 Activating vascular system propagation; for use in the treatment of repefusion injury and bronci defects |
| 04/11/2002 | US20020041902 Fluoride as a chemoprotective and chemotheraputic agent for cancer in mammals |
| 04/11/2002 | US20020041901 Pharmaceutical compositions and methods for managing skin conditions |
| 04/11/2002 | US20020041888 Suspension containing microspheres; apoptosis inducing compound |
| 04/11/2002 | US20020041876 Modulation of angiogenesis |
| 04/11/2002 | US20020041873 Administering neutrotrophic factor inhibitor |
| 04/11/2002 | US20020041871 Phytase and enzyme |
| 04/11/2002 | US20020041869 Methods for treating cells |
| 04/11/2002 | CA2425906A1 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425266A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension |
| 04/11/2002 | CA2425169A1 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
| 04/11/2002 | CA2425124A1 Selective anxiolytic therapeutic agents |
| 04/11/2002 | CA2425072A1 Wt1 fusion polypeptides and methods for wt1 immunotherapy |
| 04/11/2002 | CA2424934A1 Association of the cb1 receptor antagonist and sibutramin, for treating obesity |
| 04/11/2002 | CA2424880A1 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 04/11/2002 | CA2424761A1 Method of treating cancer using dithiocarbamate derivatives |
| 04/11/2002 | CA2424730A1 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 04/11/2002 | CA2424623A1 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid |
| 04/11/2002 | CA2424622A1 Use of neuropeptide-y antagonists in treatment of alcoholism |
| 04/11/2002 | CA2424621A1 Combination particles for the treatment of asthma |
| 04/11/2002 | CA2424620A1 Inhalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | CA2424607A1 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 04/11/2002 | CA2424604A1 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | CA2424555A1 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 04/11/2002 | CA2424506A1 Cyclopeptides, a method for their preparation and their use as inhibitors or activators of angiogenesis |
| 04/11/2002 | CA2424222A1 Inhibitors of prenyl-protein transferase |
| 04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
| 04/11/2002 | CA2423883A1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 04/11/2002 | CA2423656A1 Methods and compositions for enhancing angiogenesis |
| 04/11/2002 | CA2423436A1 Methods and compositions for modulating t cell activation and uses thereof |
| 04/10/2002 | EP1195605A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195604A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195435A1 Truncated phosphodiesterase-7 polypeptides |
| 04/10/2002 | EP1195166A2 Use of a vasopressin antagonist such as conivaptan in the manufacture of a medicament for treating pulmonary hypertension |
| 04/10/2002 | EP1195159A1 Therapeutic combination of ascorbate with lysine or arginine for prevention and treatment of cancer |
| 04/10/2002 | EP1194777A1 Methods and compositions relating to pancreatic islet and beta-cell dysfunction |
| 04/10/2002 | EP1194595A1 Polymorphisms in the human hmg-coa reductase gene |
| 04/10/2002 | EP1194568A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 04/10/2002 | EP1194547A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 04/10/2002 | EP1194546A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 04/10/2002 | EP1194528A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 04/10/2002 | EP1194525A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 04/10/2002 | EP1194447A2 Novel potassium channels and genes encoding these potassium channels |
| 04/10/2002 | EP1194439A1 Human eag2 |
| 04/10/2002 | EP1194436A1 Sulfonamidomethyl phosphonate inhibitors of beta-lactamase |
| 04/10/2002 | EP1194409A1 Pyrazolidinol compounds |
| 04/10/2002 | EP1194404A1 Inhibitors of aspartyl protease |
| 04/10/2002 | EP1194187A1 Antibody-based treatment for streptococcus pneumoniae infection |
| 04/10/2002 | EP1194173A1 X-ray guided drug delivery |
| 04/10/2002 | EP1194168A2 Methods and products for manipulating uncoupling protein expression |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 04/10/2002 | EP1194156A1 Method of treating malignancies and viral infections and improving immune function with a dietary supplement |
| 04/10/2002 | EP1194152A1 Src kinase inhibitor compounds |
| 04/10/2002 | EP1194151A1 Integrin receptor antagonists |
| 04/10/2002 | EP1194138A1 Nutritional supplements |
| 04/10/2002 | EP1194135A2 Methods of treating fungal infections with inhibitors of nad synthetase enzyme |
| 04/10/2002 | EP1194132A2 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 04/10/2002 | EP1194122A1 Methods for preparation of lipid-encapsulated therapeutic agents |
| 04/10/2002 | EP0930885B1 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus |
| 04/10/2002 | EP0758900B1 Botulinum toxin FOR REDUCTION OF migraine HEADACHE PAIN |
| 04/10/2002 | CN1344317A 多肽 Polypeptide |
| 04/10/2002 | CN1344163A Stabilized oral pharmaceutical compsn. contg. iodide and iodate and method |
| 04/10/2002 | CN1344159A Combinations for treatment of diseases involving angiogenesis |
| 04/10/2002 | CN1344157A Use of certain offinity NMDA antagonists as antidepressants |
| 04/10/2002 | CN1344154A Absorbent article compsn. and method of use for sequestering skin irritants |
| 04/10/2002 | CN1344153A Facial tissue compsn. and method of use for sequestration of nasal secretion skin irritants |
| 04/10/2002 | CN1344146A Cosmetics |
| 04/10/2002 | CN1344135A Organ arrest, protection and preservation |
| 04/10/2002 | CN1082371C NK-1 receptor antagonist and 5HT3 receptor antagonists for treating emesis |
| 04/10/2002 | CN1082369C Formulations contg. carotenoids and procarotenoids combined with polyphenols |
| 04/09/2002 | US6369234 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 04/09/2002 | US6369114 Administration of an α2-adrenergic receptor agonist to enhance cardiopulmonary resuscitation |
| 04/09/2002 | US6369107 Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 04/09/2002 | US6369103 Hmg coa reductase inhibitor such as pravastatin to a patient which has one or more risk factors for a coronary and/or cerebrovascular event such as hypercholesterolemia |
| 04/09/2002 | US6369098 Peroxisome proliferator-activated receptor-.gamma. (ppar.gamma.) and/or ppar.alpha treatment of endocrine, skin, cardiovascular, immunological, neurological, neuropsychiatric, neoplastic and chronic viral diseases of various organs |
| 04/09/2002 | US6369095 Indole-3-carbinol (13C) derivatives and methods |
| 04/09/2002 | US6369091 Benzimidazole analogs as down-regulators of IgE |
| 04/09/2002 | US6369084 Prostaglandin mediated diseases |
| 04/09/2002 | US6369082 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 04/09/2002 | US6369075 7[4′-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and method of inhibiting the secretion of apolipoprotein B |
| 04/09/2002 | US6369070 Methods for inhibiting mrp1 |
| 04/09/2002 | US6369066 Substituted 1,3-oxathiolanes with antiviral properties |
| 04/09/2002 | US6369051 Synergistic mixtures |
| 04/09/2002 | US6369046 Administration of a glucocorticoid receptor antagonist, mifepristone |